As the only domesticated species known to exhibit both induced and spontaneous ovulation, the cat is a model for understanding the nuances of ovarian control. To explore ovarian sensitivity to exogenous gonadotropins and the influence of progestin priming, we conducted a study of queens that were down-regulated with oral progestin or allowed to cycle normally, followed by low or high doses of equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG). Our metrics included 1) fecal steroid metabolite profiles before and after ovulation induction, 2) laparoscopic examination of ovarian follicles and corpora lutea (CL) on Days 2 and 17 (Day 0 ¼ hCG administration), and 3) ovariohysterectomy (Day 17) to assess CL progesterone concentrations, morphometrics, and histology. Reproductive tracts from time-matched, naturally mated queens (n ¼ 6) served as controls. Every progestin-primed cat (n ¼ 12) produced the desired response of morphologically similar, fresh CL (regardless of eCG/hCG dose) by Day 2, whereas 41.7% of unprimed counterparts (n ¼ 12) failed to ovulate or had variable-aged CL suggestive of prior spontaneous ovulation (P , 0.05). The ovarian response to low, but not high, eCG/hCG was improved (P , 0.05) in primed compared to unprimed cats, indicating increased sensitivity to gonadotropin in the progestin-primed ovary. Progestin priming prevented hyperelevated fecal steroid metabolites and normalized CL progesterone capacity, but only when combined with low eCG/hCG. However, priming failed to prevent ancillary CL formation, smaller CL mass, or abnormal luteal cell density, which were common to all eCG/hCG-treated cats. Thus, the domestic cat exposed to eCG/hCG produces CL with structural and functional aberrations. These anomalies can be partially mitigated by progestin priming, possibly due to a protective effect of progestin associated with enhanced ovarian sensitivity to gonadotropins. corpus luteum, ovary, progesterone
INTRODUCTION
Felids (cats) express diverse reproductive mechanisms among the 37 extant species, especially with respect to ovarian function [1] . Information learned about felid reproduction has contributed to our collective understanding of mammalian reproductive physiology, including in humans [2] , and has been applied for managing domestic cat biomedical models and rare wildlife species [3, 4] . For example, years of data collection on ovarian responsiveness to exogenous gonadotropins in the domestic cat have made it possible to produce living offspring by artificial insemination (AI) or in vitro fertilization/ embryo transfer (IVF/ET) in select disease-oriented genotypes [5, 6] and wild species [7] [8] [9] , including to avoid inbreeding [10] . The ability to apply assisted reproductive techniques is critical for ex situ management of felids, which can be notoriously difficult to successfully pair because of aggression and mate preference [1, 11] .
Most felids ovulate only after copulatory stimulation elicits a sufficient luteinizing hormone (LH) surge, the phenomenon of induced ovulation [1, 12] . However, it is now well established that not all cats release ova via this mechanism, with several species, notably the clouded leopard (Neofelis nebulosa) [13] , fishing cat (Prionailurus viverrinus) [14] , margay (Leopardus wiedii) [15] , and black-footed cat (Felis nigripes) [16] , primarily or episodically ovulating spontaneously at the culmination of estrus and in the absence of external stimuli. Interestingly, although the domestic cat has long been classified as an induced ovulator [17] , a subpopulation of individuals consistently release ova spontaneously [18] [19] [20] . This variance in ovulatory approach among and even within felid species illustrates the challenge in understanding ovarian control and folliculogenesis across this taxon.
In general, follicular maturation and ovulation are artificially provoked in felids using single doses of equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG) given 80-84 h apart [21, 22] . These gonadotropins are longacting [23] and highly stimulative, which is advantageous when working with intractable, wild species where drugs often must be given via a remote delivery system. The disadvantage is that both eCG and hCG elicit ancillary follicular development and accessory corpora lutea (CL) after the initial response [24] as well as alterations in steroidogenic capacity [25] , reduced embryo quality [26] , and delayed oviductal transport [27] . These findings are similar to observations in other mammalian species following exposure to chorionic gonadotropins [28] [29] [30] . Furthermore, a standard gonadotropin protocol that is effective for an induced ovulator often is unsuitable for a spontaneously ovulating counterpart. For example, it is wellknown that the presence of fresh luteal tissue derived from spontaneous ovulation (and concomitant elevations in circulating progesterone) prevents a normative ovarian response to exogenous gonadotropins [31, 32] . From an applied research perspective, variation in ovulatory phenotype has made it difficult to develop reliable protocols for ovarian stimulation. Although offspring have been produced using AI and/or IVF/ ET in about one-third of extant felid species [3, 7, 33] , overall pregnancy success remains low (,10%) [34] . Not surprising, lower AI success is observed in wild felids that express spontaneous [35, 36] compared to induced [37, 38] ovulation, suggesting that preexisting CL at the time of ovulation induction may interfere with ovarian responsiveness to exogenous gonadotropins and possibly alter the peri-implantation endocrine milieu.
Short-term ovarian down-regulation with exogenous steroids or gonadotropin releasing hormone analogs has been used to improve ovulation induction or timed breeding in domesticated animals-cow [39] , pig [40] , horse [41] , and sheep [42] -and in diverse wildlife species-sable antelope (Hippotragus niger [43] ), scimitar-horned oryx (Oryx dammah [44] ), killer whale (Orcinus orca [45] ), and bottlenose dolphin (Tursiops truncatus [46] ). Our laboratory has explored several approaches to ovarian suppression in cats and has concluded that a regimen of daily oral progestin provides rapid, consistent, and reversible inhibition of ovarian activity [47] . There is good evidence that upon withdrawal, the progestinprimed ovary has the capacity to produce 1) a more consistent endocrine and ovarian response to exogenous gonadotropins [31, 32] and 2) high quality, fertilizable oocytes that are developmentally competent in vitro [31] . We also have measured more normative hormonal and ovulatory patterns in cats that are naturally primed with endogenous progesterone (via spontaneous ovulation) [31, 32] . Nonetheless, progestin priming does nothing to alleviate perturbed endocrine patterns associated with gonadotropin exposure, specifically extended and superelevated estradiol surges, at least at standard eCG/ hCG dosages [32] . Meanwhile, no information is available on how progestin priming might affect luteal morphology and CL steroidogenesis after exogenous gonadotropin exposure, and if there are potential influences on successful implantation.
Our objective was to use an integrative, multidisciplinary (endocrine, morphological, histological) approach to assess the precise influence of oral progestin priming on ovarian sensitivity to exogenous gonadotropins, including evaluating a lower than normal eCG/hCG dosage combination. We also took the opportunity to explore the interaction of gonadotropin dosage and progestin priming on specific peri-implantation endpoints associated with luteal structure and function. These metrics were further evaluated in the context of whether an individual displayed induced versus spontaneous ovulatory cycles during the pretreatment monitoring period. We hypothesized that progestin priming in the cat acts by enhancing ovarian sensitivity to gonadotropins, producing normalized endocrine dynamics and luteal function compared to unprimed individuals.
MATERIALS AND METHODS

Animals
Thirty adult (1-to 3-yr-old) female domestic cats, part of a long-term research colony at the Smithsonian Conservation Biology Institute (SCBI), were maintained individually (n ¼ 11 queens) or in same sex pairs (n ¼ 19) under artificial fluorescent light (12L:12D) in stainless steel enclosures (minimum 0.5 m 3 per individual). Three proven breeder (1-to 7-yr-old) male conspecifics were housed individually in a similar environment in an adjacent room. All the cats were provided a dry commercial diet (Purina One, Nestlé Purina PetCare Co., St. Louis, MO) and had continual access to water, perch boards, bedding, and enrichment items. This research was approved by the Institutional Animal Care and Use Committees at SCBI (05-25) and the University of Maryland, College Park (R-06-07).
Experimental Design
The SCBI cat colony is known to be comprised of queens that exhibit either strictly anovulatory estrous cycles (i.e., induced ovulators) or a combination of anovulatory and ovulatory cycles (designated here as spontaneous ovulators) [19, 27, 47] . The investigators had no knowledge a priori of the ovulation patterns of females assigned to the current study, although this same colony recently has exhibited spontaneous ovulation at a prevalence of 38% [32] to 56% [19] of all cats.
The experimental design involved randomly assigning most females (n ¼ 24) to undergo ovulation induction using one of two exogenous gonadotropin dosage combinations administered 1) at a random time in the estrous cycle or 2) after receiving an oral progestin regimen given to achieve short-term ovarian suppression [47] . The gonadotropin dosages were based on earlier studies that routinely relied on a single 100 international units (IU) injection of eCG followed by a hCG injection of at least 50 IU or higher [26, 48] , designated here as the high dose. The specific treatment combinations were: 1) progestin þ 50 IU eCG þ 37.5 IU hCG (i.e., P þ low eCG/hCG; n ¼ 7); 2) 50 IU eCG þ 37.5 IU hCG (i.e., low eCG/hCG; n ¼ 7); 3) progestin þ 100 IU eCG þ 75 IU hCG (i.e., P þ high eCG/hCG; n ¼ 5); or 4) 100 IU eCG þ 75 IU hCG (i.e., high eCG/hCG; n ¼ 5). All the cats were examined laparoscopically on Day 2 for evidence of ovulation (Day 0 ¼ day of hCG administration; see details of assessment below). A subset of cats from each group also was monitored longitudinally for fecal steroidogenic capacity, examined laparoscopically on Day 17 to recount CL number (i.e., to quantify ancillary CL formation), and ovariohysterectomized on Day 17 to assess CL morphometrics and progesterone concentrations (see below). The remaining six cats (from the original 30) were considered controls, bred during a random estrus with a proven male to induce ovulation (natural breeding, NB), and then spayed to provide comparative, time-matched luteal tissues. Tissues recovered after being spayed also were used for histological assessments in three targeted treatment groups (P þ low eCG/hCG, low eCG/hCG, and NB) as described below.
Ovulation Induction and NB
Queens undergoing ovulation induction had no previous exogenous gonadotropin exposure [49] . For those animals designated for ovarian suppression, 0.088 mg/kg daily of altrenogest (Regu-Mate; Intervet Inc., Millsboro, DE) was provided to rapidly suppress follicular activity [47] . To ensure complete ovarian quiescence by the time of eCG/hCG administration, progestin was administered in 5 g of canned food (Friskies; Nestlé Purina) for 38 consecutive days [47] . Unprimed females received canned food only. Three days after the last progestin dose or randomly in the unprimed treatment groups, ovarian responsiveness was tested by administering a single intramuscular (i.m.) injection of eCG (Sigma-Aldrich Chemical Co., St. Louis, MO) to initiate follicular growth followed 80 h later by a single i.m. injection of hCG (SigmaAldrich) to stimulate final follicular maturation and ovulation. This timed induction protocol has been used extensively to provoke ovarian activity in a wide range of felid species, including the domestic cat [36, 38, 48, [50] [51] [52] [53] .
Each control queen designated for NB was monitored daily by briefly hand stimulating the perineum to determine signs of behavioral estrus, including tail deviation, vocalization, rolling, and lordosis. Beginning on the second to fourth day of estrus, one proven breeder male was introduced into the female's enclosure and allowed to mate three times per day (in 3-h intervals) for two consecutive days, a protocol known effective for inducing ovulation in naturally estrual queens [17, 54, 55] . The first day of breeding was designated Day 0 to time-match ovulation with the gonadotropin-treated counterparts [26] .
Fecal Hormonal Analyses
Ovarian steroid metabolites were measured in feces to confirm that gonadal suppression occurred during progestin treatment and to measure steroidogenic activity in response to ovulation induction. We monitored daily fecal estrogens and progestagens in a subset of queens beginning 60 days before giving any exogenous hormone (termed pretreatment) and continuing until 2 days after ovariohysterectomy. This included cats treated with: 1) P þ low eCG/hCG (n ¼ 5); 2) low eCG/hCG (n ¼ 4); 3) P þ high eCG/hCG (n ¼ 5); and 4) high eCG/ hCG (n ¼ 5). In paired queens, one cat from each duo received one drop of concentrated green food dye (Wilton Industries, Woodbridge, IL) in the canned STEWART ET AL.
food to differentiate feces. Whole fecal samples were collected into a labeled, plastic bag and stored at À208C. Samples were dried, pulverized, and processed for subsequent hormonal analysis using an ethanol extraction technique validated in our laboratory for the cat [25, 47] .
A single antibody, estrogen conjugate enzyme immunoassay (EIA) was modified to quantify estrogens [45, 56] in cat fecal extracts. The polyclonal antibody (1:20 000 anti-EC R522-2; supplied by C. Munro, University of California, Davis, CA) cross-reacted with a broad range of estrogen metabolites previously identified in cat feces by high-performance liquid chromatography [25] . Antisera in coating buffer (0.015 M Na 2 CO 3 , 0.035 M NaHCO 3 , pH 9.6) was added to a 96-well, flat-bottom microtiter plate (Nunc-Immuno; Fisher Scientific Company, Pittsburgh, PA) and incubated overnight at 48C. The plate was washed (0.05% Tween 20 in 0.15 M NaCl solution), and 0.025 ml assay buffer (0.2 M NaH 2 PO 4 , 0.2 M Na 2 HPO 4 , 0.15 M NaCl, 2.0 g/L bovine serum albumin, pH 7.0) was added to each well. An aliquot (0.05 ml) of diluted fecal extract (range, 1:100-1:1000) or estrone-glucuronide standard (range, 0.78-200 pg; Sigma-Aldrich) was added to wells in duplicate immediately followed by 0.05 ml of enzyme conjugate (1:15 000 of E1G horseradish peroxidase; from C. Munro). After a 2-h incubation at room temperature, the plate was washed, and 0.1 ml substrate (0.04 M 2,2 0 -azino-bis(3-ethylbenzothiazoline-6-sulphonic acid, 0.5 M H 2 O 2 in a 0.05 M citric acid solution) was added to each well. The optical density (OD) was read using a microplate reader (MRX; Dynex Technologies, Chantilly, VA) at 405 nm when 0 pg standard wells reached an OD of 0.9 to 1. Serial dilutions of cat fecal extracts yielded displacement curves that were parallel to the standard curve (R 2 ¼ 0.98). Recovery of known amounts of estrone-glucuronide standard added to a pool of domestic cat fecal extracts was 51.2% 6 15.0% (y ¼ 0.89x À 3.9; R 2 ¼ 0.99). The intraassay variation was ,10%, and the interassay variations were 8.0% and 9.8% at ;30% and 70% binding, respectively (n ¼ 82 plates). Progestagen metabolites were quantified in fecal extracts using a pregnane EIA previously validated for this species [47] . The intraassay variation was ,10%, and the interassay variations were 7.8% and 14.8% at ;30% and 70% binding, respectively (n ¼ 95 plates).
Laparoscopy and Ovariohysterectomy
Ovarian morphology in the cat has been well characterized laparoscopically, allowing the differentiation of follicular versus luteal structures including, for the latter, fresh versus aged CL [48, 57] . A laparoscopic ovarian examination was performed 36-40 h after hCG administration (Day 2) in all queens receiving exogenous gonadotropins. This postovulatory time interval was chosen because it corresponds with the best conception success by artificial insemination in this species [48] . Females were maintained in a surgical plane of anesthesia with 10 mg/kg ketamine hydrochloride (Vedco Inc., St. Joseph, MO), 1 mg/kg acepromazine maleate (Phoenix Pharmaceuticals, Inc., St. Joseph, MO), and isoflurane inhalant gas (Phoenix). All aspects of each ovary, including CL and follicles, were documented and recorded using an integrated laparoscopic camera system (Olympus Surgical and Industrial America, Orangeburg, NY) [21] . CL that were pink or red in coloration with developing vascularization were termed fresh. In contrast, CL that were white or pale yellow in coloration with extensive vascularization were termed aged. As none of our research females were housed with males, these latter CL were recognized to be derived from spontaneous ovulations. In contrast to CL, follicles (recorded when !2 mm in diameter) were more flattened in height and translucent, and those demonstrating mild-to-moderate vascularization were termed mature. Paired ovaries from each individual were graded collectively on a 1 to 4 scale ( Fig. 1) to provide a quantitative assessment of overall ovarian response. Grade 1 ovaries (excellent response) had multiple (.2) fresh CL with no aged CL or mature follicles; grade 2 ovaries (good) had a mixed cohort of fresh CL and mature follicles with no aged CL; grade 3 ovaries (fair) had a mixed cohort of aged and fresh CL with or without mature follicles; and grade 4 ovaries (poor) had only aged CL or complete ovulation failure.
To assess ancillary CL formation (i.e., ovulation of secondary follicles developed from a residual exogenous gonadotropin effect) [24] , a second laparoscopic examination was conducted in a subset of each eCG/hCG-treated group (n ¼ 4 to 5 cats per treatment) on Day 17 as described above. This time was chosen because Day 17 is midway through the average luteal phase and coincides with the peri-implantation interval [58] . After documenting and photographing ovarian activity laparoscopically, each queen underwent immediate ovariohysterectomy to excise both whole ovaries. Naturally bred, control queens were ovariohysterectomized on Day 17 using an identical protocol to obtain time-matched tissues. Individual CL were surgically excised from one ovary of each pair. After taking morphological measurements with calipers and weighing, half of the CL were flash-frozen in liquid nitrogen for subsequent progesterone analysis, and the other half were treated with RNAlater (Ambion Inc., Austin, TX) and archived at À808C for gene expression analyses (data not shown). The contralateral ovary was bisected longitudinally, and one hemiovary was fixed in 4% paraformaldehyde (Fisher Scientific) before being embedded in paraffin and step-sectioned by a commercial company (HistoServ, Rockville, MD). Four equally spaced 5-lm sections across the ovary were mounted and stained with hemotoxylin and eosin (H&E) for histology. The remaining hemiovary was fixed in tissuefreezing medium and archived at À808C.
Luteal Progesterone and Histology
Luteal progesterone was extracted from flash-frozen CL (n ¼ 113) and quantified with an 125 I progesterone radioimmunoassay kit (Coat-a-Count; Diagnostic Products Corporation, Los Angeles, CA) according to the methods of Swanson et al. [59] . The intraassay variation was ,10%, and the interassay variation was 5.1%.
Because laparoscopy data revealed that ovarian response in primed cats was only improved with lower gonadotropin dosages (see Results), our histological assessments focused on individuals from 1) P þ low eCG/hCG (n ¼ 5), 2) low eCG/hCG (n ¼ 5), and 3) NB (n ¼ 5); sections from the sixth NB female were unusable because of tissue damage during processing. The aim of this assessment was to both characterize basic ovarian histology and compare CL histomorphometrics among treatments. Four H&E-stained sections from each cat were evaluated for the presence or absence of primordial/primary, secondary, tertiary, and atretic follicles as well as CL [60] . In brief, this involved identifying primordial and primary follicles as those containing an oocyte surrounded by small, poorly differentiated cell layers. Secondary follicles had several granulosa cell layers surrounding an oocyte, but no visible antrum. A tertiary follicle was one with a more clearly visible oocyte, welldifferentiated granulosa and theca cells, and an enlarged, distinctive antrum. By contrast, an atretic follicle lacked an oocyte and showed evidence of hypertrophy and irregular follicular margins. Luteal tissue was assessed for PROGESTIN PRIMING AND OVARIAN SENSITIVITY cell type (polygonal versus fusiform), presence or absence of a central cavity (evidence of very recent ancillary ovulation), and lipid vacuoles (indicating spontaneous ovulation from a previous cycle) [60] . Surface area of individual CL was measured with IP Lab for Windows Version 3.5.1 software (Scanalytics Inc., Fairfax, VA). CL were outlined with the region of interest freehand-drawing tool, and number of pixels contained within the outline was recorded. A measure of relative cell density was obtained by capturing TIFF images of each CL in each section at 2003 and then overlaying the digital image with a uniform square grid in Microsoft Office PowerPoint 2003 (Microsoft Corporation, Redmond, WA). All the nuclei contained within the grid were counted, and the cell density was expressed as number of nuclei per unit area.
Statistical Analyses
For hormonal data, baseline and elevated fecal steroid concentrations during the 60-day pretreatment period were determined for each individual using an iterative process [47] . A follicular phase was defined as any continuous period of elevated estrogens (minimum two consecutive days) with a transient return to baseline for no longer than 2 days. The highest estrogen value within an array of elevations was denoted as the peak for that follicular phase. Anovulatory estrous cycle length was calculated as the number of days between peak-elevated estrogens with no elevation in fecal progestagens. A luteal phase was defined as any period of elevated progestagens for at least three consecutive weeks. Luteal phase length was the total number of days of elevated progestagen concentrations, with the end of the luteal phase recognized when progestagens had returned to baseline for at least 4 days. Estrous cycle traits (anovulatory estrous cycle length, baseline estrogens, duration of follicular phase, mean and peak fecal estrogens/follicular phase, baseline progestagens, duration of luteal phase, mean and peak progestagens/ luteal phase) were summarized by treatment and also between induced and spontaneous ovulators. Hormonal data among treatments within a single time interval (pretreatment, gonadotropin-stimulated) were analyzed using a mixed model factorial ANOVA with least significant difference (LSD) mean comparison tests. Main effects (progestin and gonadotropin dosage) were interpreted when specific treatment groups did not differ and no interactions were present. Summarized data for induced versus spontaneous ovulating cats during the pretreatment period were compared using a one-way ANOVA followed by LSD mean comparisons. Hormonal data among treatments and between induced versus spontaneous ovulators were compared before and after gonadotropin stimulation using a mixed model repeated measures ANOVA with LSD mean comparisons.
Laparoscopic ovarian data, gross luteal mass, gross luteal diameter, and CL progesterone concentrations were evaluated among treatments using a mixed model factorial ANOVA, and between induced versus spontaneous ovulators using a one-way ANOVA as described above for the hormonal data. Changes in CL number from Day 2 to 17 were compared using a mixed model repeated measures ANOVA with LSD mean comparisons. Histomorphology was compared among treatments and between induced versus spontaneous ovulators using one-way ANOVA, and correlations between histology measurements and other study endpoints were assessed with bivariate linear regression analysis. All the analyses were conducted using JMP Versions 5.1 or 9 (SAS Institute Inc., Cary, NC) with the criteria for significance set at P , 0.05. Trends were considered if statistical significance was not observed yet noteworthy changes appeared (P ¼ 0.05-0.10). When necessary, data were transformed before analysis to meet the assumptions of the statistical model. Data are presented as means 6 SEM.
RESULTS
Fecal Steroidogenic Activity Before and After Gonadotropin Stimulation
Eight of 19 females (42.1%) produced at least one spontaneous luteal phase during the 60-day pretreatment period (Table 1) . Within this cohort, six of the eight spontaneous ovulators also expressed from one to two anovulatory estrous cycles (on the basis of elevated excreted estrogens with no progestagen rise). The remaining 11 cats displayed only anovulatory estrous cycles and were termed induced ovulators. There were no differences (P . 0.05) in anovulatory estrous cycle duration, baseline estrogen concentration, duration of the follicular phase, or mean or peak estrogen concentrations during the follicular phase between induced and spontaneous ovulators ( Table 1 ). The only difference was that baseline progestagen concentrations were higher (P , 0.01) in spontaneous compared to induced ovulators during the pretreatment period.
In most cases, administering progestin suppressed fecal steroidogenic activity for the duration of treatment ( Fig. 2A ; representative individual). However, three females already had elevated estrogens on the first day of progestin treatment and, in these cases, this existing follicular phase was sustained at a normal duration and magnitude (when compared to pretreatment data). One of these cats ovulated spontaneously (Fig. 2B) based on a rise in excreted progestagens within 5 days of beginning oral progestin and completed a normal luteal phase before returning to nadir. The other two females returned to baseline within 5-6 days of beginning oral progestin and remained suppressed for the remainder of treatment. Three cats had elevated fecal progestagens at the onset of oral progestin ( Fig. 2C; representative individual) . Luteal phase duration and mean and peak progestagens were normal, and all returned to baseline before the end of the progestin interval. Subsequently, all the progestin-treated cats exhibited baseline fecal estrogen and progestagens by the time of eCG administration. In contrast, of the nine unprimed cats, three (33.3%) had elevated estrogens ( Fig. 3A; representative individual) and two (22.2%) had elevated progestagens ( Fig. 3B ; representative individual) on the day of eCG administration.
When comparing the gonadotropin-associated follicular phase to pretreatment estrous cycle traits, there were no differences (P . 0.05) in follicular phase duration, mean estrogens/phase, or peak estrogens/phase among the treatments (data not shown). However, when data were pooled to assess the main effect of progestin priming, it was apparent that unprimed cats were hyperestrogenic in response to exogenous gonadotropins, producing unusually high (P , 0.05) mean STEWART ET AL. estrogens compared to pretreatment follicular phases or to their progestin-primed counterparts (Table 2) . Although the duration of the follicular phase was unaffected (P . 0.05) by progestin priming, unprimed cats also tended (P ¼ 0.07) to have ;2-fold higher peak estrogens after eCG/hCG (Table 2 ). This marked variation in fecal estrogen excretion between the unprimed and progestin-primed ovary is illustrated in Figure 4 for two representative cats. Whether a cat experienced spontaneous ovulation during the pretreatment period had no influence (P . 0.05) on subsequent fecal estrogen concentrations in response to exogenous gonadotropins, although induced ovulators tended (P ¼ 0.09) toward higher peak estrogens after eCG/ hCG (data not shown). The interval from the time of the hCG challenge to fecal progestagen rise was similar (P . 0.05) among treatments and averaged 4.6 6 0.3 days. However, mean progestagens during the first 17 days of the gonadotropin-associated luteal phase were unusually elevated (P , 0.05; 44.2 6 8.3 lg/g feces) in unprimed cats given high eCG/hCG compared to all the other treatment groups (range of means, 17.7 6 3.6 to 19.0 6 1.6 lg/g).
Ovarian Morphology in Response to Exogenous Gonadotropins
On Day 2 (36-40 h post-hCG), all the cats given oral progestin (n ¼ 12) had ovarian responses that met the excellent or good grading criteria compared to half (n ¼ 6) of the unprimed counterparts. Mean ovarian grade was compromised (P , 0.05) only in unprimed individuals receiving the low gonadotropin dosages (Table 3) . On this same day of evaluation, there was evidence of spontaneous ovulation in 5 of 12 (41.7%) unprimed females (range, two to eight visibly aged CL) compared to none of the 12 (0%) primed counterparts; thus, the former group had more (P , 0.05) aged CL than the latter (Table 3 ). The proportion of cats with fresh CL and the number of these CL in response to eCG/hCG reflected ovarian grade, that is, the fewest (P , 0.05) fresh ovulation sites were observed in unprimed cats given low gonadotropins (Table 3) . Fresh CL diameter was smaller (P , PROGESTIN PRIMING AND OVARIAN SENSITIVITY 0.05) in progestin-primed cats receiving high gonadotropins compared to primed and unprimed individuals administered low eCG/hCG, but was similar (P . 0.05) to their unprimed counterparts (Table 3 ). There were no differences (P . 0.05) in total number of follicles per cat or follicle size among treatments. Collectively, both groups receiving low eCG/hCG had more (P ¼ 0.01) unovulated follicles, and these follicles were larger in size (P , 0.05) compared to groups receiving high gonadotropins (Table 3) . Thus, progestin priming had no influence on the presence or characteristics of residual follicles that are common following eCG/hCG treatment.
On Day 17, ancillary CL (Fig. 5) were observed in most females (75%-100%) regardless of the treatment. Collectively, the overall CL number per individual increased by ;50%, with an average of 12.7 6 1.8 total CL on Day 2 versus 17.5 6 2.0 CL on Day 17. Within individual cats, there was a time (P , 0.001), but no treatment (P . 0.05), effect on CL number between Days 2 and 17. Likewise, having spontaneously ovulated during the 60-day pretreatment period had no influence (P . 0.05) on subsequent formation of ancillary CL (data not shown).
CL Morphometrics, Progesterone Concentrations, and Histology
Of the six NB control queens, three were pregnant and three were not on Day 17, as determined by presence of fetal gestational sac(s) in the uterine cornuae. There were no differences (P . 0.05) between these two cohorts in average CL number, morphometrics, progesterone concentration, or histology (data not shown). Thus, values for these six specimens were pooled for comparative analysis with the eCG/hCG-treatment groups. CL diameter and mass were similar (P . 0.05) among the four gonadotropin-treated groups, but the overall average diameter (3.3 6 0.1 mm) and weight (23.0 6 1.8 mg) were less (P , 0.05) than values measured in NB counterparts (3.9 6 0.2 mm and 39.2 6 5.0 mg, respectively). Naturally bred females also had numerically fewer (P , 0.05) CL (5.2 6 0.5) on Day 17 compared to the combined data from the gonadotropin-treated groups (19.2 6 2.4 CL). Mean CL progesterone concentration in the progestinprimed low eCG/hCG group (158.5 6 12.9 ng/mg tissue) was comparable (P . 0.05) to NB controls (185.2 6 17.8), but higher (P , 0.05) than the unprimed low eCG/hCG (86.4 6 11.7), unprimed high eCG/hCG (118.7 6 6.6), and primed high eCG/hCG (118.5 6 6.3) groups.
Because progestin priming combined with the lower gonadotropin doses most closely mimicked the controls in terms of luteal progesterone content on Day 17, we focused our histological analyses only on the naturally bred versus the two low eCG/hCG groups. Females from all the groups had a similar (P . 0.05) incidence of primordial and primary follicles (Fig. 6A) in the ovarian cortex (metric data not * Values are means 6 SEM. There were no differences (P . 0.05) attributed to gonadotropin dosage, so the data were pooled to compare the influence of progestin priming. One unprimed cat was excluded from the analysis because there was no pretreatment ovarian activity. z A trend (P ¼ 0.07) toward higher peak estrogens after eCG/hCG treatment was observed in unprimed cats. a,b Within a row, means with different superscripts differ (P , 0.05). STEWART ET AL.
shown). Secondary follicles (Fig. 6B) were observed in three of five NB and six of ten gonadotropin-treated (P . 0.05) cats, with the incidence unaffected (P . 0.05) by progestin priming. Likewise, tertiary follicles (Fig. 6C) were observed in three of five NB individuals and four of ten gonadotropin-treated cats, a difference that was insignificant (P . 0.05) and unaffected by progestin priming. Luteal cells were uniformly polygonal across all the groups (Fig. 6D) . CL with central cavities (Fig.  6E) were observed in one primed and one unprimed gonadotropin-treated female, indicating recent ovulation and suggestive of protracted ancillary CL formation (;2 wk after the initial eCG/hCG response). Regressing luteal tissue with distinct lipid vacuoles was observed in the three unprimed eCG/hCG females characterized as spontaneous ovulators (Fig.  6F) . CL surface area and relative luteal cell density did not differ (P . 0.05) between primed and unprimed individuals or compared to naturally bred queens. However, when the data from the two gonadotropin-treated groups were pooled, the number of cell nuclei per unit area was higher (P , 0.05) compared to values for NB counterparts (53.3 6 3.5 versus 38.1 6 4.9 nuclei). This increased cell density was negatively correlated to CL diameter (r 2 ¼À0.52; P , 0.01) and CL mass (r 2 ¼ À0.62; P , 0.001). Whether a cat had exhibited spontaneous ovulation during the pretreatment period had no influence (P . 0.05) on subsequent histological metrics.
DISCUSSION
Earlier studies demonstrated that challenging felids with exogenous gonadotropins can result in an excessive number of ovulation sites [26] and hyperelevated, protracted estrogen secretion [61] . The present investigation has demonstrated that the common commercial gonadotropins eCG and hCG significantly alter luteal structure and function in the domestic cat, which also may partially explain the high incidence of pregnancy failure after AI and IVF/ET in gonadotropin-treated felids of diverse species [34] . It is already well-known that the cat ovary is highly responsive to eCG/hCG [1] , and we found this sensitivity was expressed even at an unusually low dosage combination (50 IU/37.5 IU, respectively) not routinely used in this species. Our research also reconfirmed long-acting residual effects of eCG/hCG [24] that provoked extra luteal formation, perturbed ovarian steroid metabolite profiles, and reduced CL progesterone content during the first 2 wk postovulation. Most importantly, we demonstrated that some of this dysfunction, including hyperelevated fecal steroid excretion and compromised luteal progesterone capacity, was mitigated by preemptive ovarian down-regulation with oral progestin. However, other anomalies associated with eCG/hCG exposure, including ancillary CL formation, reduced CL mass, and increased luteal cell density, remained unaffected by progestin priming. The mechanism by which progestin pretreatment normalized ovarian steroidogenesis appeared linked to the ability of the primed ovary to respond favorably to the lower eCG/hCG dosages, rather than a direct progesterone-mediated effect. This was confirmed by our unique access to a subpopulation of spontaneously ovulating cats, which (when combined with data from counterparts receiving oral progestin) revealed that progesterone exposure of either type (i.e., endogenous or exogenous) was incapable of overriding most negative luteal effects at usual (and higher) eCG/hCG dosages. Taken together, these findings support the incorporation of a progestin regimen before low-dose ovarian stimulation in felids. This is especially relevant for species (or populations) that experience spontaneous ovulation.
Chorionic gonadotropin exposure is strongly associated with altered endocrine profiles in felids [61] that, in turn, can lead to varying effects on the oocyte, embryo, and reproductive tract. Inadequate circulating estradiol during folliculogenesis has been linked to poor oocyte quality in the cat [62] , and gonadotropin-induced hyperestrogenism is known to retard embryo transport through the oviduct [27] . Less is known PROGESTIN PRIMING AND OVARIAN SENSITIVITY about exogenous gonadotropin effects on progesterone patterns in felids, although there is some evidence that eCG/hCG (at doses comparable to our high treatment) can hyperelevate fecal progestagens in the cat after ovulation [27] . This time interval is important, owing to progesterone's dynamic and important role in remodeling the mammalian uterus in preparation for implantation and early pregnancy [63] . We discovered from the present study that eCG/hCG influenced intraovarian follicular dynamics during the early luteal phase, and there also were marked effects on CL structure and steroidogenesis. Furthermore, our findings revealed that even extremely low eCG/hCG doses can elicit abnormalities, including ancillary CL formation and individual ovulation sites that were smaller in diameter and mass as well as compromised in progesterone concentration. Higher (i.e., standard) dosages of eCG/hCG appeared to cause additional problems, including hyperelevated fecal estrogens and progestagens, but did not necessarily heighten adverse effects detected with the low dose stimulation, at least in a dose-dependent fashion.
Short-term oral progestin indeed was capable of downregulating folliculogenesis and imposing an inactive interval that improved ovarian responsiveness to an eCG/hCG challenge. The purported mechanism by which progestin exposure down-regulates the cat ovary likely involves negative feedback at the hypothalamus and pituitary combined with direct effects on steroidogenesis and granulosa cell remodeling at the level of the ovary [32, 47] . We also confirmed that progestin exposure was unable to disrupt the trajectory of an inprogress follicular or luteal phase [19, 32, 47] . Apparently, the stage of folliculogenic progression at treatment onset dictates the ability of oral progestin to immediately quiet the ovary, which also has been reported in the horse [64] . For example, of the three cats with elevated estrogens (.200 ng/g feces) at progestin treatment onset, two (including one known spontaneous ovulator) returned to baseline and remained suppressed. The third proceeded with a spontaneous ovulation on approximately the fifth day of oral progestin. Thus, at some point in folliculogenesis, it is likely that a LH threshold is surpassed, and the ovulatory cascade cannot be overridden by sudden progestin exposure, even in a classic induced ovulator that occasionally releases ova spontaneously. The comparison of low and high gonadotropin doses demonstrated that preemptive progestin priming was clearly increasing ovarian sensitivity to subsequent ovulation induction. Our most compelling evidence was that cats given less eCG/hCG in the absence of progestin priming produced few fresh CL. This suggested that exogenous progestin was changing the ovarian landscape, increasing sensitivity to the gonadotropin after progestin withdrawal. The mechanism(s) by which this is occurring in felids remains speculative, but we suspect that priming could be directly altering gonadotropin and/or steroid receptor concentrations [32] , allowing the down-regulated ovary to respond rapidly and efficiently to even miniscule amounts of gonadotropin. There is evidence of this phenomenon in other species, including the human, rat, and dog where progesterone exposure has been linked to altered steroidogenesis and receptor populations at all levels of the hypothalamicpituitary-gonadal axis [65] [66] [67] .
Besides functional changes in ovarian responsiveness attributed to progestin pretreatment, priming also strongly STEWART ET AL.
influenced both central and peripheral endocrine dynamics. Progestin exposure prevented protracted, hyperelevated fecal estrogens after eCG/hCG, a finding at least partially supported by our spontaneously ovulating (i.e., naturally primed) controls that also trended toward lower (and normal) peak estrogens after gonadotropin stimulation. We anticipated this overall result, as a relatively quiescent ovary in the cat (or a taxonomically related species such as the cheetah [36] ) with little or no mature follicular activity has a low likelihood of hyperstimulation [34] . The observation that progestin exposure prevented hyperelevated fecal estrogen and progestagen metabolites, and normalized CL progesterone capacity only when combined with low eCG/hCG, indicated that ovarian morphology does not always match with functionality. In this case, ovarian steroid excretion was normal in unprimed individuals when clearly there were anomalies in ovarian grade as well as the amount of luteal tissue and its progesterone content. This is important because the decisions and timing of assisted breeding in felids generally are made on the basis of ovarian observations, mostly via laparoscopy [7, 68] . The diminished luteal progesterone content observed on Day 17 in our study also was noteworthy because earlier investigations reported analogous CL progesterone concentrations between gonadotropin-treated and naturally copulating cats through Day 6 (;4 days postovulation) [26, 59] . Therefore, this perturbation is delayed and occurring more than 1 wk after eCG/hCG exposure. Interestingly, concentrations of fecal progestagen after ovulation were not highly related to CL progesterone content on Day 17. Unprimed cats given the higher (standard) eCG/hCG dosages appeared to be excreting excessive amounts of fecal progestagen metabolites, while concurrently having a reduced capacity for luteal progesterone production. While potentially intriguing, we choose to consider these findings conservatively for now as we did not have unstimulated luteal progestagen concentrations available for comparison.
No doubt the adverse morphological and functional consequences of using eCG and hCG are due to these gonadotropins' large molecular weights (;64 kDa [69] and ;38 kDa [70] , respectively), which facilitate a lingering impact expressed as the formation of ancillary CL. This protracted influence is well-known in the cat [24, 48] , and Swanson et al. [23] have made the important distinction that much of this effect specifically arises from hCG. The design of our study permitted us to determine that CL number in eCG/hCGchallenged cats increased within individuals from 25% to 500% between the normal day of ovulation and about 2 wk later. While the functionality and significance of these secondary luteal structures are not well characterized in the cat [23] , a previous study has revealed their absence in naturally mated queens [17] . Ancillary CL appear to contribute to an abnormal endocrine environment in cats [27] , and we also found an association between this extra luteal tissue and hyperelevated levels of fecal estrogen and progestin metabolites. We also discovered that there was no direct cause and effect relationship because significant ancillary CL formation occurred in some eCG/hCG-treated cats that also presented normal steroid metabolite patterns as well as luteal progesterone content. Thus, in the absence of altered endocrine function, one could question if these ancillary CL are actually detrimental. For example, secondary CL are routinely provoked in the cow by exogenous hCG to increase progesterone biosynthesis and improve pregnancy outcome [71] . Nonetheless, carnivores in general and felids in particular are extraordinarily sensitive to gonadal estrogen and progesterone, with chronic exposures resulting in severe endometrial hyperplasia and uterine cancer [72, 73] . Therefore, although the relationship between presence of extra luteal tissue and excreted gonadal metabolites may not always be clear, there likely can be no fertility advantages in felids postovulation to chronically elevated estrogen or progesterone.
Corpora lutea from eCG/hCG-challenged cats were smaller in size, lighter in mass, and had increased luteal cell density compared to unstimulated, naturally mated queens. An earlier report [22] had suggested that cats given the high eCG/hCG regimen used here appear to have compromised amounts of luteal cell cytoplasm at ;10 days postovulation. Our findings confirmed that histological anomalies are extended at least another week and into the postimplantation period, even with relatively lower gonadotropin dosages. These morphological changes in CL were not amended by preemptive progestin, which was somewhat surprising given that CL progesterone content was normalized in the low eCG/hCG, progestin-primed group. Thus, it was apparent that these smaller sized CL still had the capacity to produce normal estrogen and progestagen metabolite concentrations as long as the ovary was first downregulated with progestin. Collectively, our findings consistently demonstrated that the benefit of progestin priming was less oriented to improving the ovarian landscape (i.e., structure and appearance) and more directed toward supporting normal steroidogenic function. Therefore, the way the cat ovary looks may actually have little to do with reproductive success, at least from the time of ovulation through implantation.
There is significant applied relevance to our results, especially related to improving breeding protocols for reproductive management. It is well-known that various species in the family Felidae have remarkably differing sensitivities to eCG and hCG that are predominately linked to phylogenetics and not body mass [7] . For example, small neotropical felids from South America (e.g., ocelot, Leopardus pardalis; oncilla, Leopardus tigrinus) require comparatively high eCG/hCG concentrations to induce adequate follicle development and ovulation [74] . By contrast, larger species from Southeast Asia (e.g., clouded leopard; fishing cat) are highly sensitive to these gonadotropins and require much lower dosages to avoid hyperstimulation [13, 35] . Variability in ovarian responsiveness to eCG/hCG also is confounded by increasing amounts of data showing the diversity (and even unpredictability) in prevalence of induced versus spontaneous ovulation among felids, sometime within the same species. For example, the induced ovulatory phenotype, as occurs in the tiger (Panthera tigris) [75] , sand cat (Felis margarita) [76] , and ocelot [38] , requires comparatively high eCG/hCG dosages relative to counterparts where spontaneous ovulation occurs, even sporadically (i.e., black-footed cat [76] , clouded leopard [13] , fishing cat [35] ). Our findings affirmed the relative ease of administering an oral progestin in feed, which would be logistically feasible in wild felids managed ex situ. Most importantly, progestin priming reduced the amount of eCG/ hCG required to elicit an ovulatory response, while partially alleviating adverse side effects, including perturbed hormone profiles and compromised luteal function. Eventually it will be intriguing to conduct cross-species comparisons that examine ovarian function after progestin priming and gonadotropin challenges to determine if the relationship is stronger, weaker, or the same among different felids.
In summary, our findings provide a refined understanding of ovarian control in the domestic cat model. Data indicate that progestin priming effectively down-regulated folliculogenesis and increased ovarian sensitivity to exogenous gonadotropins. In the face of a gonadotropin challenge, progestin-primed individuals were protected against hyperelevated fecal estrogens and sustained normal luteal progesterone levels into the PROGESTIN PRIMING AND OVARIAN SENSITIVITY peri-implantation interval. However, it also was apparent that preemptive progestin exposure was incapable of preventing other dysfunctions associated with the use of eCG/hCG, including ancillary CL formation, abnormal CL morphometrics, and altered luteal cell density. From a next-step research perspective, the priorities are to 1) examine embryo quality and fitness in cats where the cycle is controlled by combined progestin priming and exogenous gonadotropins and 2) determine if luteal structural changes occurring in eCG/hCGtreated individuals are influencing gene expression associated with progesterone steroidogenesis and hormone receptor populations. Projects are in progress in our laboratory in both of these arenas. From a practical perspective, these findings support the incorporation of a progestin regimen before gonadotropin stimulation in felids, especially those with a predilection for spontaneous ovulation.
